Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways - Lu, C C; Xu, Y Q; Wu, J C; Hang, P Z; Wang, Y; Wang, C; Wu, J W; Qi, J C; Zhang, Y; Du, Z M (Naunyn Schmiedebergs Arch Pharmacol, 2013)